Moleculin Biotech, Inc. Share Price
NASDAQ: MBRX$0.00
-$8.21 (--%) Moleculin Biotech, Inc. Stock Performance
Moleculin Biotech, Inc. Share Price Chart
$0.00$0.00
L
H
Moleculin Biotech, Inc. Quarterly Profit & Loss
All figures in USD
Moleculin Biotech, Inc. Annual Profit & Loss
All figures in USD
About Moleculin Biotech, Inc.
Moleculin Biotech Inc is a late-stage pharmaceutical development company currently evaluating Annamycin, also known as L-Annamycin and by its generic name naxtarubicin. The company has two additional portfolios of technologies for hard-to-treat cancers and viruses with clinical and preclinical research funded by investigators at academic institutions. The Company operates in one reportable segment, which is the development and commercialization of drug products.
Moleculin Biotech, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $8.15 | $8.21 | +1.18% |
Oct 2026 | $0.51 | $8.11 | +1,521.80% |
Sep 2026 | $0.64 | $0.50 | -27.43% |
Aug 2026 | $0.34 | $0.69 | +72.25% |
Jul 2026 | $2.62 | $0.40 | -85.69% |
Jun 2026 | $2.85 | $2.79 | +0.18% |
May 2026 | $2.51 | $2.79 | +8.98% |
Apr 2026 | $2.25 | $2.56 | +12.78% |
Mar 2026 | $2.42 | $2.27 | -5.81% |
Feb 2026 | $4.30 | $2.41 | -42.96% |
Jan 2026 | $3.32 | $4.22 | +28.22% |
Dec 2025 | $6.29 | $3.29 | +1,124.91% |